PI3K/AKT/mTOR Pathway Emerges as Central Target in Gastrointestinal Cancers
A comprehensive review finds that the PI3K/AKT/mTOR signaling axis drives progression and therapy resistance in gastrointestinal cancers, but clinical success ...
A comprehensive review finds that the PI3K/AKT/mTOR signaling axis drives progression and therapy resistance in gastrointestinal cancers, but clinical success ...
New research shows that the pyroptosis executor GSDME is upregulated in gastric cancer, where it correlates with advanced stage, immunosuppressive ...
A prospective single-center trial found that a standardized enhanced recovery pathway after gastrectomy achieved high adherence, short hospital stays, and ...
A new review maps how extracellular vesicles drive gastric cancer progression and how engineered versions could become diagnostics and drug ...
A new study reveals how the ONECUT2-YOD1-STAT3-PD-L1 signaling axis drives malignant progression and immune evasion in H. pylori-associated gastric cancer.
A review in LabMed Discovery proposes an adaptive, closed-loop precision management framework for gastric and colorectal cancers that combines spatial ...
A new review synthesizes molecular and clinical evidence that traditional Chinese medicine can ease chemotherapy-induced toxicities in gastric cancer by ...
A large Chinese multicenter study finds that 16.4 percent of locally advanced gastric cancer patients achieve a pathological complete response ...
A 2017 study linking miR-511 to TRIM24 regulation in gastric cancer has been retracted after investigators found that microRNA data ...
Molecular Cancer has retracted a 2019 gastric cancer study on circNRIP1 and microRNA-149-5p after image duplication across multiple papers and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine